Siirry sisältöön

Biovian unveils the stonemasonry work of GeneCity facility

Biovian, a leading biopharmaceutical CDMO from Finland, uncovers the stonemasonry work of its new manufacturing facility, GeneCity. Located in a growing technology hub at Turku, Kupittaa, the state-of-the-art facility houses a blend of cutting-edge equipment …
Antti Nieminen Biovian CEO

Biovian Announces Antti Nieminen as Chief Executive Officer

Biovian Oy announces that its Board of Directors has named Antti Nieminen, as a Chief Executive Officer, effective January 1st, 2022. Nieminen succeeds Co-Founder Dr. Knut Ringbom, who will transition to Senior Advisor of Biovian, …
Press Release_Lokon Pharma selects Biovian as a CDMO

Lokon Pharma AB signs an agreement with Biovian

Lokon Pharma AB, a company developing next-generation cancer therapeutics, has selected Biovian Oy as a CDMO partner for GMP manufacturing of LOAd703 for a pivotal randomized study. The uniquely engineered LOAd703 oncolytic virus is currently …